全文获取类型
收费全文 | 2315篇 |
免费 | 148篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 97篇 |
妇产科学 | 25篇 |
基础医学 | 276篇 |
口腔科学 | 115篇 |
临床医学 | 243篇 |
内科学 | 571篇 |
皮肤病学 | 33篇 |
神经病学 | 156篇 |
特种医学 | 222篇 |
外科学 | 186篇 |
综合类 | 83篇 |
预防医学 | 112篇 |
眼科学 | 34篇 |
药学 | 174篇 |
中国医学 | 24篇 |
肿瘤学 | 106篇 |
出版年
2022年 | 23篇 |
2021年 | 29篇 |
2020年 | 19篇 |
2019年 | 33篇 |
2018年 | 48篇 |
2017年 | 42篇 |
2016年 | 38篇 |
2015年 | 43篇 |
2014年 | 69篇 |
2013年 | 107篇 |
2012年 | 152篇 |
2011年 | 128篇 |
2010年 | 86篇 |
2009年 | 77篇 |
2008年 | 121篇 |
2007年 | 136篇 |
2006年 | 91篇 |
2005年 | 85篇 |
2004年 | 92篇 |
2003年 | 85篇 |
2002年 | 61篇 |
2001年 | 55篇 |
2000年 | 58篇 |
1999年 | 52篇 |
1998年 | 71篇 |
1997年 | 70篇 |
1996年 | 55篇 |
1995年 | 35篇 |
1994年 | 33篇 |
1993年 | 30篇 |
1992年 | 46篇 |
1991年 | 25篇 |
1990年 | 28篇 |
1989年 | 43篇 |
1988年 | 46篇 |
1987年 | 35篇 |
1986年 | 23篇 |
1985年 | 29篇 |
1984年 | 12篇 |
1983年 | 17篇 |
1982年 | 13篇 |
1981年 | 10篇 |
1980年 | 13篇 |
1978年 | 10篇 |
1977年 | 9篇 |
1976年 | 15篇 |
1975年 | 12篇 |
1974年 | 7篇 |
1973年 | 7篇 |
1972年 | 9篇 |
排序方式: 共有2474条查询结果,搜索用时 15 毫秒
91.
Bishop JF; Matthews JP; Young GA; Szer J; Gillett A; Joshua D; Bradstock K; Enno A; Wolf MM; Fox R 《Blood》1996,87(5):1710-1717
High-dose cytarabine (ara-c) may overcome cytarabine resistance in leukemic blasts. It has been used as a successful salvage and in postremission therapy but not as initial induction treatment. Patients aged 15 to 60 years, presenting with newly diagnosed acute myeloid leukemia (AML) were randomized to receive either high-dose cytarabine, 3 g/m2 12 hourly on days 1, 3, 5, and 7 for 8 doses, daunorubicin 50 mg/m2 days 1 to 3, etoposide 75 mg/m2 days 1 to 7, (HIDAC-3-7) or standard dose cytarabine 100 mg/m2 continuous intravenous infusion for 7 days with daunorubicin and etoposide at the same dose and schedule as above (7-3-7). Patients could receive a second or third induction course if complete remission (CR) was not achieved. All patients received the same postinduction consolidation therapy (5-2-5) for 2 courses. Eligible patients had no prior chemotherapy or myelodysplastic disease. Patients have been followed for a median of 4.5 years. Of 301 patients treated, complete response (CR) was achieved in 71% with HIDAC- 3-7 and 74% with 7-3-7. For patients in CR, the estimated median remission duration was 45 months with HIDAC-3-7 and 12 months with 7-3- 7 (P = .0005 univariate analysis, P = .0004 multivariate analysis). The estimated percentage of patients relapse free 5 years after achieving a CR was 49% on HIDAC-3-7 and 24% on 7-3-7. Patients in CR tended to survive longer with HIDAC-3-7 but there were no overall survival differences between the two arms. HIDAC-3-7 was associated with significantly more toxicity in induction with more leukopenia, thrombocytopenia, nausea, and vomiting and eye toxicity (all P < .001) but a similar incidence of severe central nervous system and cerebellar toxicity compared to 7-3-7. The consolidation treatment was the same in both arms but caused significantly more leukopenia and thrombocytopenia in patients previously treated with HIDAC-3-7 induction (P < .0001). We conclude that a dose-effect exists for cytarabine in AML and that HIDAC- 3-7 prolongs remission duration and disease-free survival and is tolerable when used as initial induction therapy in patients with de novo AML. 相似文献
92.
GA FitzGerald 《Circulation》1998,98(22):2363-2364
93.
Fibronectin binding to thrombin-stimulated platelets: evidence for fibrin(ogen) independent and dependent pathways 总被引:2,自引:0,他引:2
Plasma fibronectin binds in a specific and saturable manner to thrombin- stimulated platelets. gamma-Thrombin stimulated 80% as much fibronectin binding to platelets as alpha-thrombin with conversion of less than or equal to 1% of platelet fibrinogen to fibrin. Afibrinogenemic and normal platelets bound similar quantities of fibronectin in the presence of calcium or magnesium-ethylene glycol tetra-acetic acid (EGTA). These observations indicate that fibronectin can interact with platelets without involvement of fibrin or fibrinogen. Nevertheless, two different effects of fibrin(ogen) on fibronectin binding were observed. First, exogenous fibrinogen inhibited fibronectin binding to thrombin-stimulated platelets. This inhibition was unidirectional, as fibronectin did not inhibit fibrinogen binding to ADP or thrombin- stimulated cells. Second, formaldehyde-fixed cells with surface- associated fibrin bound significant quantities of fibronectin. This interaction required calcium and did not occur on fixed cells with or without surface-bound fibrinogen. A portion of the ligand bound to fixed cells with surface-associated fibrin was modified to form a derivative with a molecular weight identical to that of the fibronectin subunit cross-linked to the alpha-chain of fibrin. This high mol wt derivative was also observed to a variable extent with living cells in the presence of magnesium or calcium but not in the presence of magnesium-EGTA. Thus, fibronectin binds to platelets by at least two mechanisms: (1) a fibrin(ogen)-independent pathway that requires divalent ions and is inhibited by exogenous fibrinogen; and (2) a fibrin-dependent pathway with an absolute calcium requirement. With nonaggregated, thrombin-stimulated platelets, the former pathway appears to predominate. 相似文献
94.
Tommaso Sanna Antonio Dello Russo Daniela Toniolo Michal Vytopil Gemma Pelargonio Giuseppe De Martino Enzo Ricci Gabriella Silvestri Vincenzo Giglio Loredana Messano Elisabetta Zachara Fulvio Bellocci 《European heart journal》2003,24(24):2227-2236
AIMS: Retrospective studies have identified a mutation in the lamin A/C (LMNA) gene in patients selected on the basis of a phenotype characterized by dilated cardiomyopathy, atrioventricular conduction disturbances and sudden death. However, the features of cardiac abnormalities in patients with an initial diagnosis of Emery-Dreifuss muscular dystrophy (EDMD) are poorly known. Aim of the present study was to investigate the spectrum of cardiac disease in patients with an initial diagnosis of EDMD caused by a mutation in the LMNA gene. METHODS AND RESULTS: Ten consecutive patients with EDMD and a LMNA gene mutation were evaluated with structured medical interview, physical examination, ECG, echocardiogram and 24-h Holter monitoring. Electrophysiological testing and cardiac catheterization were performed if a class 1 or 2 American Heart Association guidelines indication was present. Cardiac disease was found in eight of 10 patients and consisted in the variable combination of supraventricular arrhythmias, disorders of atrioventricular conduction, ventricular arrhythmias, dilated cardiomyopathy, non-dilated cardiomyopathy, restrictive cardiomyopathy and sudden death despite pacemaker implant. CONCLUSIONS: Cardiac disease is common in patients with an initial diagnosis of EDMD caused by a mutation in the LMNA gene and consists of arrhythmias, disorders of atrioventricular conduction, cardiomyopathies and sudden death despite pacemaker implant. 相似文献
95.
96.
97.
98.
目的 检索并获取脑卒中患者二级预防管理的相关证据,并对最佳证据进行总结。方法 系统检索15个数据库,涉及脑卒中二级预防管理的所有文献,包括指南、专家共识、证据总结、系统评价。检索时限为建库至2022年2月。由2名研究者独立对文献进行质量评价,并对符合标准的文献进行证据提取与总结。结果 共纳入15篇文献,包括指南5篇、专家共识2篇、证据总结2篇、系统评价6篇,最终总结出34条证据。结论 本研究通过总结脑卒中二级预防管理的最佳证据,旨在为临床实践提供循证依据,从而提高医务人员对脑卒中患者二级预防管理的关注度和管理的科学性。 相似文献
99.
100.
Giuseppe de Vito Lapo Turrini Caroline Müllenbroich Pietro Ricci Giuseppe Sancataldo Giacomo Mazzamuto Natascia Tiso Leonardo Sacconi Duccio Fanelli Ludovico Silvestri Francesco Vanzi Francesco Saverio Pavone 《Biomedical optics express》2022,13(3):1516
Light-sheet fluorescence microscopy (LSFM) enables real-time whole-brain functional imaging in zebrafish larvae. Conventional one-photon LSFM can however induce undesirable visual stimulation due to the use of visible excitation light. The use of two-photon (2P) excitation, employing near-infrared invisible light, provides unbiased investigation of neuronal circuit dynamics. However, due to the low efficiency of the 2P absorption process, the imaging speed of this technique is typically limited by the signal-to-noise-ratio. Here, we describe a 2P LSFM setup designed for non-invasive imaging that enables quintuplicating state-of-the-art volumetric acquisition rate of the larval zebrafish brain (5 Hz) while keeping low the laser intensity on the specimen. We applied our system to the study of pharmacologically-induced acute seizures, characterizing the spatial-temporal dynamics of pathological activity and describing for the first time the appearance of caudo-rostral ictal waves (CRIWs). 相似文献